Kurze Antwort — Was ist IGF-1 LR3?
IGF-1 LR3 is a peptide supplied as a lyophilized powder for reconstitution. The information on this page describes published preclinical and early clinical literature; it is not medical advice or dosing guidance. Read our linked guide for the complete evidence summary.
IGF-1 LR3 Peptid
IGF-1 LR3 (Insulin-Like Growth Factor-1 Long R3) is a modified analog of insulin-like growth factor-1 designed for studies involving cellular growth signaling, anabolic pathways, and metabolic regulation. This extended variant contains structural modifications that increase its stability and prolong its biological activity compared to standard IGF-1, allowing users to study sustained IGF-1 receptor activation in clinical models. IGF-1 LR3 interacts with IGF-1 receptors involved in cellular proliferation, protein synthesis, and nutrient utilization. Due to its extended half-life and reduced binding to IGF-binding proteins, it provides a useful framework for examining mechanisms related to tissue growth, metabolic efficiency, and cellular repair processes. Studies suggest IGF-1 LR3 may support pathways associated with muscle cell growth, enhanced protein synthesis, improved recovery from physical stress, and regulation of glucose metabolism. Its activity also makes it valuable for investigating regenerative signaling, cellular differentiation, and anabolic responses in controlled experimental environments.
Produktübersicht
IGF-1 LR3 is a synthetic peptide classified as a modified insulin-like growth factor analog engineered to extend biological stability and receptor interaction duration in clinical models. With the molecular formula C400H625N111O115S9 and molar mass of 9117.60 g/mol, IGF-1 LR3 peptide is widely studied in experimental clinical settings focusing on cellular growth pathways and metabolic signaling. Each vial contains 0.1 mg or 1 mg of lyophilized IGF-1 LR3 supplied in high purity lyophilized form designed for clinical investigation. The peptide is valued for its structural modifications that reduce binding to IGF-binding proteins and prolong receptor activity in controlled studies environments.
Published Evidence
IGF-1 LR3 peptide is commonly utilized in clinical investigation of cellular growth signaling and anabolic pathway activity. In vitro studies frequently examine IGF-1 receptor activation and downstream intracellular signaling mechanisms associated with protein synthesis and nutrient utilization. Pre-clinical models use IGF-1 LR3 for studies to analyze cellular proliferation patterns and metabolic regulation responses. Users also explore tissue culture environments where growth factor signaling can be measured under controlled experimental conditions. IGF-1 LR3 supports investigations into cellular differentiation, metabolic signaling cascades, and anabolic response pathways. These applications provide valuable insight into mechanisms associated with growth signaling networks in experimental clinical settings.
Rekonstitution und Handhabung
Lyophilized IGF-1 LR3 should be reconstituted using bacteriostatic water in a sterile clinical environment. Users should apply strict aseptic technique when introducing solvent into the vial to preserve peptide integrity and experimental accuracy. Inject the solution slowly along the inner vial wall to prevent peptide destabilization. Avoid shaking the vial; instead, gently swirl until the lyophilized IGF-1 LR3 powder is fully dissolved. After reconstitution, store the solution at 2–8°C and maintain it in a controlled clinical environment. Proper handling procedures help preserve the stability of IGF-1 LR3 peptide for consistent experimental outcomes.
Wirkmechanismus
IGF-1 LR3 peptide interacts primarily with insulin-like growth factor receptors involved in cellular growth and metabolic signaling. In experimental clinical settings, this interaction stimulates intracellular pathways related to protein synthesis, nutrient uptake, and cellular proliferation markers. The structural modification of IGF-1 LR3 reduces affinity for IGF-binding proteins, allowing sustained receptor activation in clinical models. In vitro studies indicate that this prolonged signaling may influence pathways related to anabolic cellular responses. Users use IGF-1 LR3 for studies to explore receptor activation dynamics and downstream molecular cascades. These mechanisms provide insight into regulatory processes associated with cellular growth and metabolic adaptation.
Dosierungsrichtlinien
Dosing ranges reported in published experimental literature vary depending on the model system and assay design. In vitro investigations often use IGF-1 LR3 peptide concentrations measured in nanomolar to micromolar ranges depending on cell line sensitivity. Pre-clinical experimental models may adjust concentration parameters to evaluate receptor signaling responses and metabolic activity markers. Users should determine optimal concentration ranges through preliminary assay validation. Lyophilized IGF-1 LR3 should be prepared and measured carefully to maintain experimental consistency.
Potential Benefits
- Zelluläre Reaktionsmarker im Zusammenhang mit Wachstumsfaktor-Signalübertragung
- Gewebekulturbeobachtungen der Aktivierung anaboler Signalwege
- Stabilität der Signalaktivität in simulierten metabolischen Umgebungen
- Potenzial der Rezeptorinteraktion mit IGF-1-Signalwegen
- Angiogene und proliferative Signalwegmarker
Experimentelle Beobachtungen
Clinical investigations involving IGF-1 LR3 peptide often observe enhanced signaling activity within IGF-1 receptor pathways in controlled experimental conditions. In vitro cell culture models demonstrate measurable changes in cellular proliferation markers and protein synthesis indicators. Users studying metabolic signaling frequently document changes in nutrient uptake pathways when IGF-1 LR3 is introduced to experimental systems. Pre-clinical models have also examined IGF-1 LR3 in relation to differentiation signaling and cellular development patterns. These observations contribute to understanding how sustained receptor activation influences complex cellular networks. IGF-1 LR3 therefore provides a reproducible framework for studying anabolic signaling pathways in experimental clinical settings.
Considerations
Users working with IGF-1 LR3 should ensure strict clinical protocols are followed to maintain peptide stability and experimental validity. Environmental conditions such as temperature, solvent compatibility, and assay sensitivity can influence peptide behavior in vitro studies. Careful calibration of concentrations is recommended before initiating extended clinical investigation. IGF-1 LR3 peptide may interact with other growth factors or signaling molecules within complex experimental systems. Documentation of handling procedures and experimental parameters is essential for reproducibility. All work involving IGF-1 LR3 must remain within approved studies and clinical use guidelines.
Sicherheitshinweis
IGF-1 LR3 peptide should be handled using standard clinical safety practices including protective equipment and appropriate containment procedures. Users must ensure that the compound is stored, handled, and disposed of according to institutional clinical safety guidelines. Direct exposure should be minimized and clinical-grade handling tools should be used when preparing experimental solutions. This peptide is intended exclusively for scientific investigation and must not be used outside of controlled studies environments. The information provided is for educational and scientific reference and should not be interpreted as medical advice or as a recommendation for any form of administration. Users should follow all applicable regulations and institutional guidelines when handling this material.
Lagerungshinweise
Store lyophilized IGF-1 LR3 at −20°C for long-term storage to maintain peptide stability and structural integrity. For short-term clinical use, the peptide may be stored at 2–8°C under controlled refrigeration conditions. Protect IGF-1 LR3 from direct light exposure to prevent degradation of the peptide structure. Avoid repeated freeze-thaw cycles as these may reduce peptide stability and affect experimental reproducibility. When stored properly, IGF-1 LR3 maintains a shelf life of approximately 36 months. Proper storage ensures reliable clinical performance of lyophilized IGF-1 LR3 for studies.
Reinheit & Qualität
All IGF-1 LR3 vials stocked by MedsBase are supplied at 99%+ HPLC purity in lyophilized form. A certificate of analysis (COA) is available on request — message our support team after placing your order and we will forward the batch-specific COA for the vials you received. It is sold. Some peptides in this class have been used in early-phase clinical trials but no major regulator has issued a marketing authorization for the indications discussed in the popular literature.
Wie wird IGF-1 LR3 rekonstituiert?
Lyophilisierte Peptide werden typischerweise mit bakterienstatischem Wasser oder sterilem Wasser zur Injektion (BWFI / SWFI) in einer für die geplante Dosis geeigneten Konzentration rekonstituiert. Geben Sie das Verdünnungsmittel langsam an der Innenwand des Fläschchens hinzu — spritzen Sie den Strahl nicht direkt in das Pulver oder schütteln Sie es kräftig, da beides das Peptid denaturiert. Schwenken Sie das Fläschchen vorsichtig, bis es vollständig gelöst ist. Rekonstituierte Peptide werden typischerweise gekühlt bei 2–8°C gelagert.
Wie sollte IGF-1 LR3 gelagert werden?
Lyophilisierte Fläschchen sind bei Lagerung bei −20°C oder gekühlt bei 2–8°C, fern von direktem Licht, über längere Zeit stabil. Nach der Rekonstitution sind die meisten Peptide je nach Puffer und spezifischem Peptid 14–30 Tage im Kühlschrank haltbar. Lesen Sie stets das beiliegende Analysezertifikat für die vom Lieferanten empfohlenen Lagerungs- und Stabilitätsdaten.
What does the published literature shows?
The published literature on IGF-1 LR3 is summarized in our linked guide. We separate preclinical (rodent / cell-culture) data, where it is consistent and reproducible, from clinical-trial data, where evidence is typically thinner. We also flag where popular online claims outrun the published record.
Ist IGF-1 LR3 legal international zu bestellen?
Peptides occupy an ambiguous regulatory space. Importation rules vary by country and have changed in several jurisdictions over the past few years. It is the buyer’s responsibility to confirm import legality in their destination country before ordering. MedsBase ships peptides worldwide via our dedicated peptide courier; orders that contravene the destination country’s import rules may be detained at customs.
Was ist die Halbwertszeit von IGF-1 LR3?
IGF-1 LR3 has an estimated half-life of 20–30 hours in preclinical studies — dramatically longer than native IGF-1 (approximately 6–8 hours). The LR3 modification reduces IGF-binding protein (IGFBP) affinity, increasing the free (bioavailable) IGF-1 fraction in circulation and extending active duration.
Wie unterscheidet sich IGF-1 LR3 von nativem IGF-1?
IGF-1 LR3 is an 83-amino-acid analog of the naturally occurring 70-amino-acid IGF-1. The LR3 modification significantly reduces binding to the six known IGF-binding proteins (IGFBPs), which normally sequester ~98% of endogenous IGF-1. This results in a substantially higher free-peptide fraction and extended half-life, making IGF-1 LR3 a preferred compound in studies requiring prolonged IGF-1 receptor activation.
Kann ich IGF-1 LR3 zusammen mit anderen Peptiden bestellen?
Yes. Peptide orders are bundled and ship together via our peptide-only courier service. Lyophilized vials are protective for the duration of standard international transit. See our peptide category page for the full stocked range and the “Best Peptides for Recovery” comparison guide for stacking considerations from the published literature.
IGF-1 LR3-Protokolle beinhalten häufig BPC-157 und TB-500 zur Unterstützung von Gelenken und Sehnen während der IGF-getriebenen anabolen Phase; unser Peptide Healing Stack (BPC-157 5 mg + TB-500 5 mg + bakteriostatischem Wasser) Bündel enthält sowohl lyophilisierte Fläschchen als auch Rekonstitutionswasser zum Peptid-Versandpreis von $0.
Other Peptides for Recovery and Performance
- BPC-157 — Body Protection Compound — tendon, ligament, gut recovery
- TB-500 — Thymosin Beta-4 fragment — soft tissue and vascular recovery
- Ipamorelin — Selektiver Ghrelin-Agonist — sauberer GH-Puls ohne Cortisol/Prolaktin
- CJC-1295 mit DAC — GHRH-Analogon mit verlängerter Halbwertszeit
- GHK-Cu — Copper peptide — skin and connective tissue regeneration
Weiterführende Literatur
📖 Learn the science behind this peptide
Lesen Sie unseren vollständigen evidenzbasierten Leitfaden: IGF-1 LR3 — seriöse Wissenschaft, Dosierung & Sicherheit. Covers mechanism of action, published study data, typical dosing ranges, reconstitution protocols, stacking considerations, and safety/contraindication notes.
📦 Jede Bestellung ist durch unsere Reshipment Assurance Policy abgedeckt — wenn Ihr Paket nicht innerhalb von 20 Werktagen ankommt, versenden wir es erneut.
| Spezifikation | Detail |
|---|---|
| CAS-Nummer | 946870-92-4 |
| Molekularformel | C400H625N111O120S9 |
| Molekulargewicht | ~9117.4 Da |
| Sequenz | Long R3 IGF-1 (83 Aminosäuren; N-terminales MFPAMPLSSLFVNGPRTLCGAELVDALQFVCGDRGFYFNKPTGYGSSSRRAPQTGIVDECCFRSCDLRRLEMYCAPLKPAKSA) |
| Form | Lyophilisat (oder wie geliefert) |
| Reinheit | ≥99% (HPLC-bestätigt, COA auf Anfrage) |
| Lagerung | Lyophilisat: 2–8 °C (Kühlschrank) für Arbeitsvorrat; −20 °C zur Langzeitlagerung ungeöffneter Fläschchen. Rekonstituierte Lösung: 2–8 °C, innerhalb von ~30 Tagen verbrauchen. Vermeiden Sie starkes Schütteln; große Peptide denaturieren durch Erschütterung. Einfrieren und Auftauen der rekonstituierten Lösung vermeiden. |
| Löslichkeit | Bakteriostatisches Wasser (empfohlen) oder steriles Wasser für kürzere Anwendungszeiträume |













Bewertungen
Es gibt noch keine Bewertungen.